Service by

Home Journal Issues Guide for Authors Editorial Board About Aims & Scope Editorial Contact


Editorial Open Access


Prophylaxis and Treatment for Leptospirosis: Where are the Evidences?

Jaykaran Charan, Deepak Saxena, Summaiya Mulla.

Cited by (2)

Abstract
Leptospirosis is a zoonosis of worldwide distribution, caused by infection with pathogenic spirochetes of genus leptospira. The disease is maintained in nature by chronic renal infection of carrier mammals like rats, cattles, dogs etc, which excrete the organism in their urine.Humans get infection when come into contact with the contaminated environment like water or vegetation and the organism penetrates through the broken skin or mucosa.Leptospirosis is one on those many diseases which expresses itself in the form of outbreaks associated with seasonal variations like rainfall. Pathogenic organism responsible for this disease is a spirochete of genus Leptospira which exists in around 300 serovars.

Key words: Leptospirosis, Treatment, Prophylaxis, Antibiotics, Penicillin


 
ARTICLE TOOLS
Abstract
PDF Fulltext
Print this article Print this Article
How to cite this articleHow to cite this article
Export to
Export to
Related Records
 Articles by Jaykaran Charan
Articles by Deepak Saxena
Articles by Summaiya Mulla
on Google
on Google Scholar
Article Statistics
 Viewed: 6478
Downloaded: 1583
Cited: 2


REFERENCES
1. Perez J, Brescia F, Becam J, Goarant C. Deciphering leptospirosis ecoepidemiology in New Caledonia.BMC Proceedings 2011;5:P110.


2. Desvars A, Cardinale E, Michault A. Animal leptospirosis in small tropical areas. Epidemiol Infect 2011;139:167-88.
http://dx.doi.org/10.1017/S0950268810002074
[
Pubmed]   

3. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 2003;3:757-771.
http://dx.doi.org/10.1016/S1473-3099(03)00830-2


4. Sehgal SC, Sugunan AP, Vijayachari P: Leptospirosis: disease burden estimation and surveillance networking in India. South East Asian J Trop Med Pub Hlth 2003; 34:170-177.


5. Human leptospirosis: guidance for diagnosis, surveillance and control. Geneva, World Health Organization/ International Leptospirosis Society, 2003 (ISBN 92 4 154589 5;http://whqlibdoc.who.int/hq/2003/WHO_CDS_CSR_EPH_2002.23.pdf).


6. Takafuji ET, Kirkpatric JW, Miller RN, Karwacki JJ, Kelley PW, Gray MR. An efficacy trial of doxycycline chemoprophylazis against leptospirosis. N Engl J Med 1984:310:497-500.
http://dx.doi.org/10.1056/NEJM198402233100805
[
Pubmed]   

7. Gonsalez CR, Casseb J, Monteiro FG, Paula-Neto JB, Fernandez RB, Silva MV, et al. Use of doxycycline for leptospirosis after high risk exposure in Saopaulo, Brazil. Rev Inst Med Trop Sao Paulo1998;40:59-61.
http://dx.doi.org/10.1590/S0036-46651998000100012


8. Sehgal SC, Sugunan AP, Murhekar MV, Sharma S, Vijayachari P. Randomised controlled trial of doxycycline prophylaxis against leptospirosis in an endemic area. Int J Antimicrob Agents 2000;13:249-55.
http://dx.doi.org/10.1016/S0924-8579(99)00134-X


9. Brett-Major DM, Lipnick RJ. Antibiotic prophylaxis for leptospirosis. Cochrane Database of Systematic Reviews 2009, Issue3. Art. No.:CD007342. [DOI via Crossref]    http://dx.doi.org/10.1002/14651858.CD007342.pub2
[Pubmed]   

10. Lllangasekera VLU, Kularatne SAM, Kumarasiri PVR, Pussepitiya DMURK, Premaratne MDN. Is oral penicillin an effective chemoprophylaxis against leptospirosis? A placebo controlled field study inthe Kandy district, Srilanka. South eastAsian J Trop Med Public Health 2008;39:882-884.
[
Pubmed]   

11. Tully CC, Hinkle MK, McCall S, Griffith ME, Murray CK, Hospenthal DR. Efficacy of minocycline and tigecycline in a hamster model of leptospirosis. Diagn Microbiol Infect Dis 2011;71:366-9.
http://dx.doi.org/10.1016/j.diagmicrobio.2011.08.018
[
Pubmed]   

12. Harris BM, Blatz PJ, Hinkle MK, McCall S, Beckius ML, Mende K, et al. In vitro and in vivo activity of first generation cephalosporins against Leptospira. Am J Trop Med Hyg 2011;85:905-8.
http://dx.doi.org/10.4269/ajtmh.2011.11-0352
[
Pubmed]   

13. Chakraborty A, Miyahara S, Villanueva YAM, Gloriani NG, Yoshida S. In vitro sensitivity and resistance of 46 leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents. Antimicrob Agents Chemother 2010;54:5403-5405.
http://dx.doi.org/10.1128/AAC.00973-10
[
Pubmed]    [PMC Free Fulltext]   

14. Griffith ME, Moon JE, Johnson EN, Clark KP, Hawley JS, Hospenthal DR, et al. Efficacy of fluoroquinolones against leptospira interrogans in a hamster model. Antimicrob Agents Chemother 2007;51:2615-2617.
http://dx.doi.org/10.1128/AAC.00240-07
[
Pubmed]    [PMC Free Fulltext]   

15. Murray CK, Hospenthal DR. Determination of susceptibilities of 26 leptospira sp. Serovars to 24 antimicrobial agents by a broth microdilution techniques. Antimicrob Agents Chemother 2004;48:4002-4005.
http://dx.doi.org/10.1128/AAC.48.10.4002-4005.2004
[
Pubmed]    [PMC Free Fulltext]   

16. Moon JE, Ellis MC, Griffith ME, Hawley JS, Rivard RG, McCall S, et al. Efficacy of macrolides and telithromycine against leptospirosis in a hamster model. Antimicrob Agents Chemother 2006:50:1989-1992.
http://dx.doi.org/10.1128/AAC.01467-05
[
Pubmed]    [PMC Free Fulltext]   

17. Alexander AD, Rule PL. Penicillins, Cephalosporins, and tetracyclines in treatment of hamster with fatal leptospirosis. Antimicrob Agents Chemother 1986;30:835-839.
http://dx.doi.org/10.1128/AAC.30.6.835
[
Pubmed]    [PMC Free Fulltext]   

18. Fairburn AC, Semple SJG. Chloramphenicol and penicillin in the treatment of leptospirosis among British troops in Malaya. Lancet 1956;1:13–6.
http://dx.doi.org/10.1016/S0140-6736(56)91853-0


19. Russell RW R. Treatment of leptospirosis with oxytetracycline. Lancet 1958; 2: 1143.
http://dx.doi.org/10.1016/S0140-6736(58)92405-X


20. McClain JBL, Ballou WR, Harrison SM, Steinweg DL: Doxycycline therapy for leptospirosis. Ann Intern Med 1984; 100:696-698.
[
Pubmed]   

21. Watt G, Padre LP, Tuazon ML, Calubaquib C, Santiago E, Ranoa CP, Laughlin LW. Placebocontrolled trial of intravenous penicillin for severe and late leptospirosis. Lancet 1988;1:433–435.
http://dx.doi.org/10.1016/S0140-6736(88)91230-5


22. Edwards C N, Nicholson G D, Hassell T A, Everard C O R, Callender J. Penicillin therapy in icteric leptospirosis. Am J Trop Med Hyg 1988;39:388–390.
[
Pubmed]   

23. Daher EF, Nogueira CB. Evaluation of penicillin therapy in patients with leptospirosis and acute renal failure. Rev Inst Med Trop Sao Paulo 2000;42:327-32.
http://dx.doi.org/10.1590/S0036-46652000000600005


24. Costa E, Lopes AA, Sacramento E, Costa YA, Matos ED, Lopes MB, et al. Penicillin at the late stage of leptospirosis: a randomized controlled trial. Rev Inst Med Trop Sao Paulo 2003;45:141-5.
http://dx.doi.org/10.1590/S0036-46652003000300005


25. Panaphut T, Domrongkitchaiporn S, Vibhagool A, Thinkamrop B, Susaengrat W. Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis. Clin Infect Dis 2003;36:1507-1513.
http://dx.doi.org/10.1086/375226
[
Pubmed]   

26. Suputtamongkol, Y., K. Niwattayakul, C. Suttinont, K. Losuwanaluk, R. Limpaiboon, W. Chierakul, V. Wuthiekanum, S. Triengrim, M. Chenchittikul, N. J. White. An open, randomized, controlled trial of penicillin, doxycycline, and cefotaxime for patients with severe leptospirosis. Clin Infect Dis 2004;39:1417-1424.
http://dx.doi.org/10.1086/425001
[
Pubmed]   

27. Phimda K, Hoontrakul S, Suttinont C, Chareonwat S, Losuwanaluk K, Chueasuwanchai S, et al. Doxycycline versus azithromycin for treatment of leptospirosis and scrub typhus. Antimicrob Agents Chemother 2007;51:3259-3263.
http://dx.doi.org/10.1128/AAC.00508-07
[
Pubmed]    [PMC Free Fulltext]   

28. Brett-Major DM, Coldren R. Antibiotics for leptospirosis. Cochrane Database Syst Rev 2012 Feb 15;2:CD008264.
[
Pubmed]   

29. Segura ER, Ganoza CA, Campos K, Ricaldi JN, Torres S, Silva H, et al. Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis. 2005;40:343-51.
http://dx.doi.org/10.1086/427110
[
Pubmed]    [PMC Free Fulltext]   

30. Sinha A, Sugunan AP, Rasheed MA, Vijayachari P, Sehgal SC, Singh SS. Clinico-epidemiological study of hospitalized cases of severe leptospirosis. Indian J Med Res 1999;109:94-8.
[
Pubmed]   

31. Trivedi SV, Chavda RK, Wadia PZ, Sheth V, Bhagade PN, Trivedi SP, et al. The role of glucocoricoid pulse therapy in pulmonary involvement in leptospirosis. J Assoc Physician India 2001;49:901-3.
[
Pubmed]   

32. Abraham L, Lakshmanakumar VK, Eapen CK, Joseph MR. Methylprednisolone as adjuvant in treatment of acute respiratory distress syndrome owing to leptospirosis- a pilot study. Indian J Crit Care Med 2005;9:133-136.
http://dx.doi.org/10.4103/0972-5229.19677


33. Shenoy VV, Nagar VS, Chowdhury AA, Bhalgat PS, Juvale NI. Pulmonary leptospirosis: an excellent response to bolus methylprednisolone. Postgrad Med J 2006;82:602-606.
http://dx.doi.org/10.1136/pgmj.2005.044255
[
Pubmed]    [PMC Free Fulltext]   

34. Villanueva R, Onoya C. Use of steroid in leptospirosis to improve survival: an exploratory study. Philippine Journal of Microbiology and Infectious Diseases 2010;39:71-75.


35. Kularatne SA, Budagoda BD, de Alwis VK, Wickramasinghe WM, Bandara JM, Pathirage LP, et al. High efficacy of bolus methylprednisolone in severe leptospirosis: a descriptive study in Sri Lanka. Postgrad Med J 2011;87:13-7.
http://dx.doi.org/10.1136/pgmj.2009.092734
[
Pubmed]   

36. Niwattayakul K, Kaewtasi S, Chueasuwanchai S, Hoontrakul S, Chareonwat S, Suttinont C, et al. An open randomized controlled trial of desmopressin and pulse dexamethasone as adjunct therapy in patients with pulmonary involvement associated with severe leptospirosis. Clin Microbiol Infect 2010;16:1207-12.
http://dx.doi.org/10.1111/j.1469-0691.2009.03037.x
[
Pubmed]   

37. Trivedi SV, Vasava AH, Patel TC, Bhatia LC. Cyclophosphamide in pulmonary alveolar haemorrhage due to leptospirosis. Indian J Crit Care Med 2009;13:79-84.
http://dx.doi.org/10.4103/0972-5229.56053
[
Pubmed]    [PMC Free Fulltext]   

This Article Cited By the following articles

The Use of Chemoprophylaxis after Floods to Reduce the Occurrence and Impact of Leptospirosis Outbreaks
IJERPH 2017; 14(6): 594.

1
 
Trends of articles published in National Journal of Physiology, Pharmacy and Pharmacology NJPPP
National Journal of Physiology, Pharmacy and Pharmacology 2013; 3(2): 102.

2
 

How to Cite this Article
Pubmed Style

Charan J, Saxena D, Mulla S. Prophylaxis and Treatment for Leptospirosis: Where are the Evidences?. Natl J Physiol Pharm Pharmacol. 2012; 2(2): 78-83. doi:10.5455/njppp.2012.2.78-83


Web Style

Charan J, Saxena D, Mulla S. Prophylaxis and Treatment for Leptospirosis: Where are the Evidences?. http://www.njppp.com/?mno=22043 [Access: January 23, 2018]. doi:10.5455/njppp.2012.2.78-83


AMA (American Medical Association) Style

Charan J, Saxena D, Mulla S. Prophylaxis and Treatment for Leptospirosis: Where are the Evidences?. Natl J Physiol Pharm Pharmacol. 2012; 2(2): 78-83. doi:10.5455/njppp.2012.2.78-83



Vancouver/ICMJE Style

Charan J, Saxena D, Mulla S. Prophylaxis and Treatment for Leptospirosis: Where are the Evidences?. Natl J Physiol Pharm Pharmacol. (2012), [cited January 23, 2018]; 2(2): 78-83. doi:10.5455/njppp.2012.2.78-83



Harvard Style

Charan, J., Saxena, D. & Mulla, S. (2012) Prophylaxis and Treatment for Leptospirosis: Where are the Evidences?. Natl J Physiol Pharm Pharmacol, 2 (2), 78-83. doi:10.5455/njppp.2012.2.78-83



Turabian Style

Charan, Jaykaran, Deepak Saxena, and Summaiya Mulla. 2012. Prophylaxis and Treatment for Leptospirosis: Where are the Evidences?. National Journal of Physiology, Pharmacy and Pharmacology, 2 (2), 78-83. doi:10.5455/njppp.2012.2.78-83



Chicago Style

Charan, Jaykaran, Deepak Saxena, and Summaiya Mulla. "Prophylaxis and Treatment for Leptospirosis: Where are the Evidences?." National Journal of Physiology, Pharmacy and Pharmacology 2 (2012), 78-83. doi:10.5455/njppp.2012.2.78-83



MLA (The Modern Language Association) Style

Charan, Jaykaran, Deepak Saxena, and Summaiya Mulla. "Prophylaxis and Treatment for Leptospirosis: Where are the Evidences?." National Journal of Physiology, Pharmacy and Pharmacology 2.2 (2012), 78-83. Print. doi:10.5455/njppp.2012.2.78-83



APA (American Psychological Association) Style

Charan, J., Saxena, D. & Mulla, S. (2012) Prophylaxis and Treatment for Leptospirosis: Where are the Evidences?. National Journal of Physiology, Pharmacy and Pharmacology, 2 (2), 78-83. doi:10.5455/njppp.2012.2.78-83



AUTHOR LOGIN

REVIEWER LOGIN

Indexed In

 

National Journal of Physiology, Pharmacy and Pharmacology is Indexed in -

EMBASE

Index Copernicus  (ICV 2016: 109)

Index Medicus for SEAR

CAB abstract/Global Health

CINAHL

Hinari

Google Scholar

ScopeMed

Ulrich’s International Periodical Directory

Indian Science Abstracts

Open J- Gate

Geneva Foundation for Medical Education and Research

NewJour

PSOAR

InformIndia

EBSCO Publishing Electronic Database

Genamics JournalSeek

ProQuest

Index Scholar

SafetyLit

Chemical Abstracts Service (CAS)

Gale's Health Reference Center

Gale Info Trac

Gale Academic Onefile

Ind Medica

Scirus

Scientific Publication Index

Scientific Resources Database

Recent Science Index

Scholarly Journals Index

Directory of Academic Resources

Elite Scientific Journals Archives

Current Index to Scholarly Journals

Digital Journals Database

Academic Papers Database

Contemporary Research Index

Ayush Web Portal

CiteFactor

 

 

 

 

 

 

Journal Membership

World Association of Medical Editors (WAME), Dallas, Texas, USA

 

Journal Listed in

ICMJE- International Committee of Medical Journal Editors

HIFA 2015 – Healthcare Information for All by 2015, Charlbury, Oxfordshire, UK 

 

 


The articles in this Journal are open access articles licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-sa/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.